Edited by: Lukas Tamm Hemagglutinin (HA), the trimeric spike of influenza virus, catalyzes fusion of viral and cellular membranes. We have synthesized the anchoring peptide including the linker, transmembrane region and cytoplasmic tail (HA-TMR-CT) in a cell-free system. Furthermore, to mimic the palmitoylation of three conserved cysteines within the CT, we chemically alkylated HA-TMR-CT using hexadecyl-methanethiosulfonate. While the nuclear magnetic resonance spectroscopy showed pure and refolded peptides, the formation of multiple oligomers of higher order impeded further structural analysis. Circular dichroism spectroscopy of both alkylated and nonalkylated HA-TMR-CT revealed an a-helical secondary structure. No major impact of the fatty acids on the secondary structure was detected.
Introduction
The glycoprotein hemagglutinin (HA) of influenza virus mediates receptor binding and catalyzes fusion of viral and endosomal membranes to allow virus entry (Skehel and Wiley, 2000) . In addition, HA molecules participate in virus assembly and may drive budding of virus particles (Chen and Lamb, 2008) . The known HA subtypes of influenza A virus fall into two major phylogenetic groupings, Group 1 (H1 group) and Group 2 (H3 group), each of which is further divided into three clades: (H1, H2, H5, H6 and H17), (H11, H13 and H16) and (H8, H9 and H12) and two clades: (H3, H4 and H14) and (H7, H10 and H15) (Nobusawa et al., 1991; Pica and Palese, 2013) .
The crystal structure of the ectodomain has been resolved for many HA subtypes (Skehel and Wiley, 2000) , but very little structural information is available on the membrane-anchoring region. It is composed of a nine amino acid linker region, that remains in the viral membrane when the HA ectodomain is removed by proteolytical digestion, a 27 amino acid long transmembrane region (TMR) and a short (11 amino acid) cytoplasmic tail (CT). The CT contains two through all HA variants conserved cysteines, which are post-translationally palmitoylated (C16 : 0) and one highly conserved cysteine at the end of the TMR which is predominantly acylated with stearate (C 18 : 0) (Veit et al., 1991; Kordyukova et al., 2008) . The C-terminal region of HA does not function simply as a membrane anchor, but the TMR, the CT and, especially, the covalently bound fatty acids are crucial for raft localization of the molecule, for virus assembly and for opening and widening of the fusion pore during virus entry (Chen et al., 2005; Wagner et al., 2005; Engel et al., 2010; Ge and Freed, 2011; Gerl et al., 2012; Veit et al., 2013) .
A 30 residue peptide representing the TMR of X-31 HA (H3 subtype, Group 2) was predominantly a-helical in detergent micelles and in phospholipid bilayers as assessed by circular dichroism (CD) and attenuated total reflection Fourier transform infrared spectroscopy (Tatulian and Tamm, 2000) . On reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS -PAGE), i.e. in SDS-micelles, the peptide aggregated into heat-resistant oligomers composed of two to five molecules. Molecular dynamics (MD) simulation of a 27 residue TMR peptide from H5 subtype HA (Group 1) revealed a mostly a-helical, tilted structure when embedded into a phospholipid bilayer. If three copies of the peptide were incorporated into bilayer they oriented in a triangular parallel association thought to resemble the structure of native trimeric HA (Victor et al., 2012) . Using biochemical methods (susceptibility of viral HA to proteolytical digestion) and molecular modeling, we recently revealed that Group 2 HA TMRs are more densely packed in homotrimers compared with the Group 1 ones (Kordyukova et al., 2011) .
However, none of the modeled peptides contained CT and they, especially, lacked crucial fatty acid modifications. Here, we have synthesized a 47 residue peptide containing a linker region, complete TMR and CT (HA-TMR-CT) and chemically alkylated it with hexadecyl-methanethiosulfonate (Hd-MTS) to mimic acylation of cysteines.
Materials and methods

Cloning and cell-free production of HA-TMR-CT
The nucleotide sequence of the HA-TMR-CT peptide encoding the C-terminal region of A/FPV/Rostock/34 (H7N1) HA was constructed from six overlapping synthetic oligonucleotides using a three-stage polymerase chain reaction and cloned into pET20b(þ) (Novagen) using the restriction sites NdeI and HindIII. The peptide was synthesized in the continuous exchange cell-free expression system based on the Escherichia coli S30 extract using published protocols (Khabibullina et al., 2010; Mineev et al., 2011) . Protein synthesis was performed by incubation for 20 h at 308C under moderate stirring. The reaction mixture (RM) was centrifuged for 15 min at 14 000 rpm and analyzed with 12% SDS-PAGE under reducing conditions. Coomassie staining showed that HA-TMR-CT is present exclusively as a precipitate in the unsoluble fraction of the RM (Fig. 1 ).
15
N-labeled HA-TMR-CT was synthesized by replacement of amino acids both in the RM and feeding mixture (FM) with 15 N-algal amino acids mixture (Isotec TM ) with a final concentration of 3.1 mg/ml. In addition, 15 N-tryptophane, unlabeled asparagine and cysteine were added to the RM and FM to final concentrations of 2.3, 1.5 and 1.3 mM, respectively. Mutant HA-TMRC21S-CT was produced analogously. The subsequent purification procedure is described in Supplementary material. One-dimensional nuclear magnetic resonance (NMR) spectroscopy revealed that the peptide preparation is around 98% pure ( Supplementary Fig. S1A ). The SDS-PAGE of the purified HA-TMR-CT revealed no major products except for various oligomeric forms of the peptide (Supplementary Fig. S1B ).
Alkylation of HA-TMRC21S-CT with Hd-MTS
The peptide was dissolved in 500 ml hexafluoroisopropanol (HFIP, concentration 200 mM) with addition of 1 mM of trimethylsilylpropanoic acid (TSP; nine protons at 0.0 ppm). Hd-MTS (Toronto Research Lab) was dissolved in HFIP and added to the peptide at a concentration of 1.2 or 6 mM (2 -10 molar excess relative to each cysteine). Samples were incubated at 408C in NMR tubes for various time periods.
13 C-1 H heteronuclear single quantum coherence (HSQC) spectra were acquired to control the redox state of cysteines. The signal from the methane-sulfinic acid at 2.37 ppm was used to monitor the progress of the reaction ( Supplementary Fig. S3 ).
To remove the remainder of Hd-MTS, the modified peptide was precipitated in acetone, dried in a speed vac, washed several times by cold acetone and re-solubilized in HFIP. The quality of the purification was controlled by NMR spectroscopy.
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Aliquots (1 ml) of the sample in HFIP was mixed on a steel target with an equal volume of 2,5-dihydroxybenzoic acid (Aldrich) (10 mg/ml in 30% acetonitrile/0.5% trifluoroacetic acid (TFA)). Mass spectra were recorded on an Ultraflex II MALDI TOF-TOF mass spectrometer (Bruker Daltonik, Germany) equipped with a 355 nm (Nd) laser. The MH þ molecular ions were measured in linear mode with 0.05% accuracy.
Reconstitution of peptides into membrane-like media
The phospholipids (1, 2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)/1,2-dicaproyl-1-sn-glycero-3-phosphocholine (DHPC), 1 : 2.5) or detergents (1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-(1-glycerol)] (LMPG); dodecyl-phosphocholine (DPC)) were added to the HA-TMR-CT or HA-TMRC21S-CT dissolved in HFIP (300 ml; 100-300 mM) at various lipid (detergent)/peptide ratios (40 : 1, 100 : 1, 400 : 1, 1000 : 1 and 2000 : 1). The obtained mixtures were diluted gradually by small portions of water (50 ml) until the solution began to bubble. Following lyophilization, samples were dissolved in 50 mN phosphate buffer (pH 6.0) containing 5 mM tris(2-carboxyethyl)phosphine, 5% D 2 O, 0.3 mM TSP. The suspensions were sonicated in an ultrasound bath for 15 min and centrifuged at 13 000 rpm for 1 min. The supernatant was filled in the NMR tube. The samples were clear indicating that the protein was efficiently incorporated into the lipid vesicles.
NMR-spectroscopy and dynamic light scattering NMR spectra were acquired at 408C on 600 and 800 MHz Avance III spectrometers (Bruker BioSpin, Rheinstetten, Germany) equipped with pulsed-field gradient triple-resonance cryoprobes. C HSQC spectra were recorded to characterize the oligomeric state of the protein and the redox state of its cysteine residues. The (bicelle) particle size was determined using the DynaPro Titan instrument (Wyatt Technology Corporation, Santa Barbara, CA, USA) followed by analysis with DYNAMICS 6.7.6 software (Wyatt Technology Corporation).
Reconstitution of peptides into large unilamellar vesicles for optical spectroscopy
Lyophylized peptides (0.5 mg) were dissolved in 1.5 ml HFIP and insoluble material was sedimented until the solution became clear. Two compositions of lipids were used: (i) 70% phospholipids (phosphatidylcholine (PC) : phosphatidylserine (PS) ¼ 2 : 1), 30% cholesterol (endoplasmic reticulum (ER)-like) or (ii) 30% phospholipids (PC : PS ¼ 2 : 1), 50% cholesterol, 20% sphingolipids (sphingomyelin from bovine brain, Sigma #S7004) (plasma membrane (PM)-like). One milliliter of lipid solution (0.5 mg/ml, chloroform/methanol ¼ 3 : 1) containing 2 mM nitrobenzoxadiazole-phosphoethanolamine (NBD-PE) was mixed in glass tubes with 0.6 ml alkylated and 0.75 ml nonalkylated HA-TMRC21S-CT in HFIP, respectively, to yield a Fig. 1 . SDS-PAGE analysis and Coomassie staining of cell-free synthesis of HA-TMR-CT. Lane 1-molecular weight markers; lanes 2, 5, 8 and 11-RM after synthesis; lanes 3, 6, 9 and 12-soluble fraction of the RM after synthesis and centrifugation; lanes 4, 7, 10 and 13-insoluble fraction of the RM. In lanes designated 'GFP' the green fluorescent protein was synthesized for control. This protein with a mass of 27 kDa appears almost exclusively in the soluble fraction of RM (lane 3). A protein with an approximate mass of 5 kDa corresponding to HA-TMR-CT (arrow) is exclusively present in the RM precipitate (lanes 7, 10 and 13). It is not detectable in the whole RM, since the precipitate is only 1% of the reaction volume. Different 15 N-algal amino acids mixture concentrations were tested (1.6, 3.1 and 6.3 mg/ml).
clear solution. The mixtures were dried under nitrogen and hydrated in 1 ml of CD-buffer (10 mM Tris, pH 8.0 and 150 mM NaF) with shaking at 378C overnight. The solution was passed through an extruder (100 nm pore size) with 11 strokes to get large unilamellar vesicles (LUVs). The volume was increased to 3 ml and adjusted to 10% sucrose in CD-buffer to ensure flotation of vesicles during subsequent centrifugation for 1 h at 100 000 rpm in a TLA 100.3 rotor (Beckman). The tube was fractionated from top into 0.5 ml fractions. Only the uppermost fraction contained lipids as was observed by fluorescence measurements based on the NBD-PE emission. LUVs were dialyzed (MWCO of 1 kDa) against CD-buffer to completely remove sucrose. The dialysed samples were directly used for optical spectroscopy (see below).
CD, fluorescence and UV spectroscopy UV spectra of LUVs in CD-buffer were recorded on a Cary 50 spectrometer (Varian) from 250 to 400 nm with 1 cm path length, a scan rate of 600 nm/min and an average time of 0.1 s. Peptide concentrations of around 3.5 mM were determined from the resulting absorption at 280 nm using the predicted extinction coefficient (ProtParam, www.expasy.ch) after subtraction of scattering.
CD experiments were performed on a Jasco J-810 spectrometer at 208C with a quartz cell of 1 mm path length. For each measurement the average of 10 scans was recorded from 240 to 194 nm with a bandwidth of 2 nm, a step size of 0.2 nm, a response time of 2 s/nm and a scan speed of 100 nm/min. To determine the secondary structure, the spectra recorded for pure vesicles were subtracted from those obtained for the peptide containing LUVs.
Fluorescence spectra were recorded on a Cary Eclipse spectrometer (Varian) with excitation at 280 nm (10 nm slit) from 300 to 450 nm (emission slit 10 nm) with a scan rate of 600 nm/min, 1 nm data interval and 0.1 s averaging time.
Result and discussion
The 47 amino acid peptide representing the H7 HA C-terminal region with the sequence: MVKLSSGYKDVILWFSFGASC FLLLAIAMGLVFIC*VKNGNMRC*TIC*I (the predicted TMR is underlined, acylated cysteine residues are marked with asterisks) was synthesized in vitro (Fig. 1 ). Among Structural investigation of influenza virus HA membrane-anchoring peptide various solvents tested (chloroform/methanol/water; trifluoroethanol (TFE)/water; TFA with subsequent transfer into chloroform/methanol; formic acid with subsequent direct transfer into a water/detergent solution or organic solvents) the acquired 15 N-labeled HA-TMR-CT peptide dissolved only in pure HFIP, which allowed recording of its NMR spectra. Concentration measurements with respect to the reference peak of TSP at 0.0 ppm showed that 4 mg of the peptide was produced in 2 ml RM. The 1 O, 15 N-HSQC spectrum confirmed the presence of one tryptophan and four glycine residues within the peptide and revealed no 15 N-labeled impurities in the sample (Fig. 2c, gray peaks) . NMR analysis conducted in HFIP allowed us to confirm the identity of the synthesized protein and revealed that it adopts an a-helical conformation (see Supplementary Fig. S4 ).
Next, we tested the incorporation of HA-TMR-CT into detergent micelles. At a high detergent/protein ratio of 1000 (mol/ mol), both in LMPG and in DPC, the spectra showed a monomeric state of HA-TMR-CT (data not shown). At low lipid/ protein ratios of 40 and 100, signals from the TMR were entirely broadened, while signals from extramembrane residues demonstrated the presence of at least seven conformational states (data not shown) implying the peptide's capability to form large oligomers.
According to Lee et al. (2008) , bicelles adopting the discoid shape provide a much more native environment for membrane proteins than spherical micelles. Thus, we reconstituted the HA-TMR-CT into the DMPC/DHPC bicelles. As follows from the tryptophan side-chain signals, the peptide inserted into the bicelles (lipid/peptide ratio of 400) adopted only three populated (oligomeric) forms (Fig. 2a, see also Supplementary  Fig. S2 ). However, the overall spectrum showed overlapping peaks and was hardly interpretable hindering further structural studies (Fig. 2b) .
To prevent excessive oligomerization that might occur via the peptide regions natively shielded from each other by covalently bound fatty acids, we applied the alkylating reagent Hd-MTS. First, cysteine 21 (non-acylated) in the middle of the TMR was substituted by a serine (HA-TMRC21S-CT). The remaining free S-H groups were modified via disulfide bridges (--S-S-(CH2)15CH3) closely resembling S-acylation of native HA (Fig. 3c) .
To monitor the progress of the reaction, we used matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis. Following overnight reaction at a 2-fold molar excess of Hd-MTS, 86% of the free cysteine positions became alkylated (Fig. 3a) , while incubation at a 10-fold molar reagent excess proceeded for 20 h led to 91-92% alkylation (Fig. 3b) . Cysteine-specific alkylation was previously achieved with peptides representing E2 of Sindbis virus using hexyldecyl-dithiopyridine, but with less efficiency (Wilkinson et al., 2000 (Wilkinson et al., , 2005 .
We then synthesized 15 N-labeled HA-TMRC21S-CT, which was alkylated for 3 days at 10-fold excess of Hd-MTS to achieve maximal extent of modification. An NMR analysis of both unmodified and modified peptides dissolved in HFIP revealed the same overall pattern of NMR signals and similar NOE distribution patterns and 3JHNHa spin couplings indicating that alkylation does not crucially alter the a-helical peptide structure (Fig. 2c, Supplementary Fig. S4 ). Yet, the NMR spectra of the alkylated peptide reconstituted into DMPC/DHPC bicelles visualized only the mobile non-transmembrane residues (Fig. 2d) , while spectra acquired in DPC micelles revealed that the peptide adopts much higher number of conformational states than the non-alkylated TM domain ( Supplementary Fig. S5 ). Addition of neither DHPC nor TFE improved the spectra. Dynamic light scattering revealed that the smallest and most abundant bicelle particles containing alkylated peptide having a size of 18 nm, while the size of the bicelles formed in the presence of unmodified HA-TMRC21S-CT are characterized by a hydrodynamic radius of 3 nm (Fig. 4) . Thus, the particles in solution and the number of conformational states adopted by HA-TMRC21S-CT are too large for complete NMR analysis.
To determine the secondary structure of HA-TMRC21S-CT, both alkylated and non-alkylated, we reconstituted them into LUVs with two different lipid compositions: (i) roughly mimicking the ER and (ii) resembling the PM (van Meer et al., 2008) .
In the case of ER-like vesicles, UV spectra revealed peptide concentrations of around 3.5 mM, i.e. ,10% of the used peptides were incorporated. Fluorescence spectra of those vesicles showed a peak at 331 nm, a characteristic feature of the tryptophan fluorescence of peptides (Fig. 5a) . The difference CD spectra revealed two minima at 208 and 220 nm and a positive signal around 195 nm for the alkylated peptide, typical features for a mainly a-helical conformation of the peptide (Fig. 5b) . In the CD spectrum of the alkylated peptide the minima at 208 nm is shifted to 214 nm. This might be due to bending of the helix, small local conformational changes, oligomerization or due to some amount of misfolded/aggregated peptide. However, the main features still indicate an a-helical conformation implying no major influence of hydrophobic modification on the peptide's secondary structure.
For peptides mixed with the PM-like lipids, the UV spectra showed no maximum around 280 nm, the fluorescence spectra did not reveal a fluorescence maximum between 300 and 350 nm and the CD-difference spectra showed no features which can be attributed to any peptide conformation. Hence, we conclude that the peptides were not (or only to a very little extent) incorporated into these more densely packed lipid vesicles (van Meer et al., 2008). In summary, we synthesized a peptide representing the complete membrane-anchoring segment of HA H7-subtype with high yield as a precipitate in a cell-free system. Furthermore, we alkylated the peptide with high efficiency to mimic S-acylation of the three C-terminal cysteine residues. NMR spectroscopy showed a pure and refolded peptide, but the formation of multiple oligomers of higher order within the DPC micelles (that is clearly more pronounced for the alkylated compared with the unmodified peptide) and the aggregation of membrane-mimetic bicelles by alkylated HA-TMR-CT impeded further structural analysis. Since the TMR of fusogenic proteins oligomerize during membrane fusion, the tendency to aggregate must not necessarily be an artifact. Moreover, the stronger tendency of alkylated peptide to oligomerize and especially to aggregate in bicelles suggests that the long aliphatic chains mimicking S-acylation do not only play a passive anchoring role, but may essentially affect the lipidic media properties. This favors the hypothesis that the HA-bound fatty acids might facilitate the transition from hemifusion to fusion pore formation (Sakai et al., 2002) . Finally, CD spectroscopy of HA-TMR-CT incorporated into liposomes with an ER-like composition confirmed an a-helical secondary structure shown earlier for the TMR of the HA H3-subtype (Tatulian and Tamm, 2000) . Neither NMR nor CD spectroscopy revealed a major difference between the alkylated and non-alkylated peptide indicating that the fatty acids have no strong impact on the secondary structure of the C-terminal anchoring region of HA. Consistent with this, MD simulations performed in bilayer environments for calnexin predicted that palmitoylation at the boundary of TMR and CT does not affect TMR's conformation but rather the orientation of the CT (Lakkaraju et al., 2012) .
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Supplementary data are available at PEDS online.
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